Trends in Blood Pressure Control in US Adult CKD Patients from 1999 to 2018
- PMID: 39898249
- PMCID: PMC11783084
- DOI: 10.7150/ijms.103107
Trends in Blood Pressure Control in US Adult CKD Patients from 1999 to 2018
Abstract
Background: Blood pressure (BP) control can slow down the progression of chronic kidney disease (CKD) and protect against cardiovascular diseases, significantly improving patient survival. Herein, we analyzed the changes in BP control in adult CKD patients with hypertension in the United States from 1999-2000 to 2017-2018. Methods: National Health and Nutrition Examination Survey (NHANES) data from 1999-2000 to 2017-2018 were analyzed, including 5,510 adult CKD patients with BP above 140/90 mmHg or those under an antihypertensive regimen. Results: The proportion of adult CKD patients with uncontrolled BP decreased from 72.9% in 1999-2000 to 46.6% in 2013-2014, then increased to 56.9% in 2017-2018. Although adult CKD patients with albumin-creatinine rate (ACR) 30-299 mg/g or ACR ≥300 mg/g were more likely to take antihypertensive medication than those with ACR <30 mg/g (PR: 2.76, 95% CI: 1.63-4.79 and PR: 4.59, 95% CI: 2.37-9.51), they were more likely to have uncontrolled BP than those with ACR <30 mg/g ((multivariable-adjusted prevalence ratio (PR): 2.25, 95% CI: 1.39-3.75 and PR: 3.14, 95% CI: 1.71-6.07). Adult CKD patients (eGFR ≥60 mL/min/1.73m2) being aware of their high BP diagnosis were less likely to take antihypertensive medication than those with eGFR 30-59 mL/min/1.73m2 (PR: 0.27, 95% CI: 0.09-0.65). Conclusions: These results show that BP control should be reinforced in adult CKD patients, particularly in those with ACR ≥300 mg/g, while patients with eGFR ≥60 mL/min/1.73m2 should enhance awareness of taking antihypertensive medication.
Keywords: chronic kidney disease; clinical practice guidelines; high blood pressure; hypertension.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures



Similar articles
-
Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.Clin J Am Soc Nephrol. 2020 Apr 7;15(4):501-510. doi: 10.2215/CJN.08840719. Epub 2020 Mar 26. Clin J Am Soc Nephrol. 2020. PMID: 32217635 Free PMC article.
-
Trends of Blood Pressure Control in Chronic Kidney Disease Among US Adults: Findings From NHANES 2011 to 2020.J Am Heart Assoc. 2024 Oct 15;13(20):e034568. doi: 10.1161/JAHA.124.034568. Epub 2024 Oct 11. J Am Heart Assoc. 2024. PMID: 39392179 Free PMC article.
-
Hypertension control and antihypertensive therapy in patients with chronic kidney disease.Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24. Am J Hypertens. 2015. PMID: 25421796
-
Hypertension in Cardiovascular and Kidney Disease: Recent Trends - Treating Two Diseases as One.Cardiorenal Med. 2024;14(1):581-587. doi: 10.1159/000541876. Epub 2024 Oct 7. Cardiorenal Med. 2024. PMID: 39374593 Review.
-
Optimal blood pressure target and measurement in patients with chronic kidney disease.Korean J Intern Med. 2019 Nov;34(6):1181-1187. doi: 10.3904/kjim.2019.164. Epub 2019 Jun 17. Korean J Intern Med. 2019. PMID: 31189302 Free PMC article. Review.
References
-
- Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105:S117–s314. - PubMed
-
- Zhao X, Kwan JYY, Yip K, Liu PP, Liu FF. Targeting metabolic dysregulation for fibrosis therapy. Nature reviews Drug discovery. 2020;19:57–75. - PubMed
-
- Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol. 2006;17:331–5. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous